ID   M3K15_HUMAN             Reviewed;        1313 AA.
AC   Q6ZN16; A2AI49; A2AI50; A6NJ61; Q5JPR4; Q6ZMV3;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   15-FEB-2017, entry version 119.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 15;
DE            EC=2.7.11.25;
DE   AltName: Full=Apoptosis signal-regulating kinase 3;
DE   AltName: Full=MAPK/ERK kinase kinase 15;
DE            Short=MEK kinase 15;
DE            Short=MEKK 15;
GN   Name=MAP3K15; Synonyms=ASK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=20362554; DOI=10.1016/j.bbrc.2010.03.164;
RA   Kaji T., Yoshida S., Kawai K., Fuchigami Y., Watanabe W., Kubodera H.,
RA   Kishimoto T.;
RT   "ASK3, a novel member of the apoptosis signal-regulating kinase
RT   family, is essential for stress-induced cell death in HeLa cells.";
RL   Biochem. Biophys. Res. Commun. 395:213-218(2010).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-994, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-192; ASN-199; HIS-226; SER-255;
RP   GLY-456; CYS-494; LEU-562; GLN-677; SER-838; LEU-993; HIS-1029;
RP   ARG-1247 AND GLU-1251.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May function in a signal transduction pathway that is
CC       activated by various cell stresses and leads to apoptosis.
CC       {ECO:0000269|PubMed:20362554}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:20362554}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Contains an N-terminal autoinhibitory domain.
CC       Activated by phosphorylation at Thr-812, inhibited by
CC       phosphorylation at Ser-924 and Ser-994 (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZN16-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZN16-2; Sequence=VSP_021038;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6ZN16-3; Sequence=VSP_021039, VSP_021040;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 2 and isoform 3 are widely expressed.
CC       Isoform 2 highest levels are observed in fetal brain, and isoform
CC       3 highest levels in pancreas, peripheral blood leukocytes, fetal
CC       brain and spleen. {ECO:0000269|PubMed:20362554}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK131412; BAD18559.1; -; mRNA.
DR   EMBL; AK131477; BAD18622.1; -; mRNA.
DR   EMBL; AL732423; CAM17478.1; -; Genomic_DNA.
DR   EMBL; AL732326; CAM17478.1; JOINED; Genomic_DNA.
DR   EMBL; AL732423; CAM17479.1; -; Genomic_DNA.
DR   EMBL; AL732326; CAM17479.1; JOINED; Genomic_DNA.
DR   EMBL; AL732326; CAM23142.1; -; Genomic_DNA.
DR   EMBL; AL732423; CAM23142.1; JOINED; Genomic_DNA.
DR   EMBL; AL732326; CAM23143.1; -; Genomic_DNA.
DR   EMBL; AL732423; CAM23143.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS35212.2; -. [Q6ZN16-1]
DR   RefSeq; NP_001001671.3; NM_001001671.3. [Q6ZN16-1]
DR   RefSeq; XP_011543813.1; XM_011545511.2. [Q6ZN16-2]
DR   UniGene; Hs.713701; -.
DR   ProteinModelPortal; Q6ZN16; -.
DR   SMR; Q6ZN16; -.
DR   BioGrid; 133293; 5.
DR   IntAct; Q6ZN16; 4.
DR   STRING; 9606.ENSP00000345629; -.
DR   BindingDB; Q6ZN16; -.
DR   ChEMBL; CHEMBL1163127; -.
DR   GuidetoPHARMACOLOGY; 2075; -.
DR   iPTMnet; Q6ZN16; -.
DR   PhosphoSitePlus; Q6ZN16; -.
DR   BioMuta; MAP3K15; -.
DR   DMDM; 116248533; -.
DR   EPD; Q6ZN16; -.
DR   PaxDb; Q6ZN16; -.
DR   PeptideAtlas; Q6ZN16; -.
DR   PRIDE; Q6ZN16; -.
DR   Ensembl; ENST00000338883; ENSP00000345629; ENSG00000180815. [Q6ZN16-1]
DR   GeneID; 389840; -.
DR   KEGG; hsa:389840; -.
DR   UCSC; uc004czj.3; human. [Q6ZN16-1]
DR   CTD; 389840; -.
DR   GeneCards; MAP3K15; -.
DR   H-InvDB; HIX0028382; -.
DR   HGNC; HGNC:31689; MAP3K15.
DR   HPA; HPA004006; -.
DR   MIM; 300820; gene.
DR   neXtProt; NX_Q6ZN16; -.
DR   OpenTargets; ENSG00000180815; -.
DR   PharmGKB; PA134935369; -.
DR   eggNOG; KOG4279; Eukaryota.
DR   eggNOG; ENOG410XQGS; LUCA.
DR   GeneTree; ENSGT00800000124036; -.
DR   HOGENOM; HOG000293286; -.
DR   HOVERGEN; HBG006305; -.
DR   InParanoid; Q6ZN16; -.
DR   KO; K13986; -.
DR   OMA; IPNTRKY; -.
DR   OrthoDB; EOG091G00SJ; -.
DR   PhylomeDB; Q6ZN16; -.
DR   TreeFam; TF105115; -.
DR   SignaLink; Q6ZN16; -.
DR   GenomeRNAi; 389840; -.
DR   PRO; PR:Q6ZN16; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000180815; -.
DR   CleanEx; HS_MAP3K15; -.
DR   ExpressionAtlas; Q6ZN16; baseline and differential.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000186; P:activation of MAPKK activity; IBA:GO_Central.
DR   InterPro; IPR025136; DUF4071.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF13281; DUF4071; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   1313       Mitogen-activated protein kinase kinase
FT                                kinase 15.
FT                                /FTId=PRO_0000253481.
FT   DOMAIN      652    908       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     658    666       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED     1179   1225       {ECO:0000255}.
FT   ACT_SITE    773    773       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     681    681       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     994    994       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    565       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021038.
FT   VAR_SEQ       1    525       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021039.
FT   VAR_SEQ     526    582       GLRFPVLVIEPTKVYQPSYVSINNEAEERTVSLWHVSPTEM
FT                                KQMHEWNFTASSIKGI -> MACLTHRNETDARMEFYSLFH
FT                                KGNKAGVQWHDLGSLQPLPPRFKRFSCLSLQSSWDY (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021040.
FT   VARIANT     192    192       A -> T (in dbSNP:rs5909299).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040716.
FT   VARIANT     199    199       S -> N (in dbSNP:rs55916006).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040717.
FT   VARIANT     226    226       D -> H (in dbSNP:rs56338727).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040718.
FT   VARIANT     255    255       R -> S (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040719.
FT   VARIANT     456    456       S -> G (in dbSNP:rs56212339).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040720.
FT   VARIANT     494    494       R -> C (in dbSNP:rs41305349).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040721.
FT   VARIANT     562    562       S -> L (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040722.
FT   VARIANT     677    677       R -> Q (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040723.
FT   VARIANT     838    838       G -> S (in dbSNP:rs56381411).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040724.
FT   VARIANT     993    993       S -> L (in dbSNP:rs56233219).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040725.
FT   VARIANT    1029   1029       N -> H (in dbSNP:rs55787622).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040726.
FT   VARIANT    1247   1247       W -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040727.
FT   VARIANT    1251   1251       Q -> E (in dbSNP:rs15943).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040728.
FT   CONFLICT    793    793       F -> L (in Ref. 1; BAD18622).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1313 AA;  147437 MW;  60751706D6AEE3E9 CRC64;
     MESGGGNAPA GALGAASESP QCPPPPGVEG AAGPAEPDGA AEGAAGGSGE GESGGGPRRA
     LRAVYVRSES SQGGAAGGPE AGARQCLLRA CEAEGAHLTS VPFGELDFGE TAVLDAFYDA
     DVAVVDMSDV SRQPSLFYHL GVRESFDMAN NVILYHDTDA DTALSLKDMV TQKNTASSGN
     YYFIPYIVTP CADYFCCESD AQRRASEYMQ PNWDNILGPL CMPLVDRFIS LLKDIHVTSC
     VYYKETLLND IRKAREKYQG EELAKELARI KLRMDNTEVL TSDIIINLLL SYRDIQDYDA
     MVKLVETLEM LPTCDLADQH NIKFHYAFAL NRRNSTGDRE KALQIMLQVL QSCDHPGPDM
     FCLCGRIYKD IFLDSDCKDD TSRDSAIEWY RKGFELQSSL YSGINLAVLL IVAGQQFETS
     LELRKIGVRL NSLLGRKGSL EKMNNYWDVG QFFSVSMLAH DVGKAVQAAE RLFKLKPPVW
     YLRSLVQNLL LIRRFKKTII EHSPRQERLN FWLDIIFEAT NEVTNGLRFP VLVIEPTKVY
     QPSYVSINNE AEERTVSLWH VSPTEMKQMH EWNFTASSIK GISLSKFDER CCFLYVHDNS
     DDFQIYFSTE EQCSRFFSLV KEMITNTAGS TVELEGETDG DTLEYEYDHD ANGERVVLGK
     GTYGIVYAGR DLSNQVRIAI KEIPERDSRY SQPLHEEIAL HKYLKHRNIV QYLGSVSENG
     YIKIFMEQVP GGSLSALLRS KWGPMKEPTI KFYTKQILEG LKYLHENQIV HRDIKGDNVL
     VNTYSGVVKI SDFGTSKRLA GVNPCTETFT GTLQYMAPEI IDQGPRGYGA PADIWSLGCT
     IIEMATSKPP FHELGEPQAA MFKVGMFKIH PEIPEALSAE ARAFILSCFE PDPHKRATTA
     ELLREGFLRQ VNKGKKNRIA FKPSEGPRGV VLALPTQGEP MATSSSEHGS VSPDSDAQPD
     ALFERTRAPR HHLGHLLSVP DESSALEDRG LASSPEDRDQ GLFLLRKDSE RRAILYKILW
     EEQNQVASNL QECVAQSSEE LHLSVGHIKQ IIGILRDFIR SPEHRVMATT ISKLKVDLDF
     DSSSISQIHL VLFGFQDAVN KILRNHLIRP HWMFAMDNII RRAVQAAVTI LIPELRAHFE
     PTCETEGVDK DMDEAEEGYP PATGPGQEAQ PHQQHLSLQL GELRQETNRL LEHLVEKERE
     YQNLLRQTLE QKTQELYHLQ LKLKSNCITE NPAGPYGQRT DKELIDWLRL QGADAKTIEK
     IVEEGYTLSD ILNEITKEDL RYLRLRGGLL CRLWSAVSQY RRAQEASETK DKA
//
